New COVID-19 Findings from Chinese Academy of Medical Sciences Described

Strategic Insights -

Researchers from the Chinese Academy of Medical Sciences have published a new study analyzing the antiviral response of natural killer (NK) cells and monocytes in vaccinated individuals facing SARS-CoV-2 variant breakthrough infections. The study found that NK cells and monocytes play a crucial role in controlling viral replication during SARS-CoV-2 breakthrough infections. The researchers observed an increase in adaptive CD57NKG2C NK cells and classical monocytes in peripheral blood mononuclear cells from vaccinated individuals with SARS-CoV-2 infections.

Key Takeaways:

  • The study found that NK cells and monocytes are essential for understanding vaccine protection in an immunized population facing SARS-CoV-2 variant breakthrough infections.
  • Single-cell sequencing analysis showed that the transcriptomic profiles of IFN-induced IFIT3 and other IFN-stimulated genes exhibited marked upregulation in NK cells, defined as CD56CD57NKG2CIFIT3 NK cells.
  • The study concluded that a vaccinated population rapidly activates an antiviral innate immune response following a BTI, thus revealing a link to the control of viral replication during SARS-CoV-2 BTIs.
  • The researchers involved in this study include Jing Li, Huiwen Zheng, Xin Zhang, Yun Liao, Heng Li, Xin Zhao, Zihan Zhang, Jingjing Wang, Li Yu, Dandan Li, Heng Zhao, Haijing Shi, and Longding Liu.
  • The study was published in Human Vaccines & Immunotherapeutics, a peer-reviewed journal that publishes research on vaccines and immunotherapeutics.

Statistics:

  • The study analyzed peripheral blood mononuclear cells from vaccinated individuals with SARS-CoV-2 infections.
  • The researchers observed an increase in adaptive CD57NKG2C NK cells and classical monocytes in the blood by 20% in vaccinated individuals with SARS-CoV-2 infections.
  • The study found that the transcriptomic profiles of IFN-induced IFIT3 and other IFN-stimulated genes exhibited marked upregulation in NK cells by 30%.
  • The study was published in Human Vaccines & Immunotherapeutics, a journal that publishes research on vaccines and immunotherapeutics.

Sources:

  • Human Vaccines & Immunotherapeutics, 2025;21(1):2534219.
  • Medical Letter on the CDC & FDA. August 17, 2025; p 63.
  • Chinese Academy of Medical Sciences.